Overview

A Translational Approach to Gitelman Syndrome

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This study will test the response to a single dose of thiazide diuretic as a diagnostic test for Gitelman syndrome. Individuals with hypokalemic alkalosis will be enrolled. After a baseline study, they will have the response to 50 mg hydrochlorothiazide on fractional chloride excretion examined.
Phase:
N/A
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
Oregon Clinical and Translational Research Institute
Treatments:
Hydrochlorothiazide